Follow-On Biologics: The Law and Intellectual Property Issues

Description:

This report reviews the Biologics Price Competition and Innovation Act of 2009 (BPCIA), within the context of intellectual property and innovation issues. It provides an introduction to the biologics industry, introduces the regulatory and intellectual property provisions of the BPCIA, considers the potential market for biosimilars and possible industry responses that may arise in the wake of this legislation, and closes with concluding observations.

Creator(s): Thomas, John R.
Location(s): United States
Creation Date: January 15, 2014
Partner(s):
UNT Libraries Government Documents Department
Collection(s):
Congressional Research Service Reports
Usage:
Total Uses: 15
Past 30 days: 5
Yesterday: 0
Creator (Author):
Thomas, John R.

Visiting Scholar

Publisher Info:
Publisher Info: Congressional Research Service, Library of Congress
Place of Publication: Washington D.C.
Date(s):
  • Creation: January 15, 2014
Coverage:
Place
United States
Description:

This report reviews the Biologics Price Competition and Innovation Act of 2009 (BPCIA), within the context of intellectual property and innovation issues. It provides an introduction to the biologics industry, introduces the regulatory and intellectual property provisions of the BPCIA, considers the potential market for biosimilars and possible industry responses that may arise in the wake of this legislation, and closes with concluding observations.

Physical Description:

24 pages.

Language(s):
Subject(s):
Partner:
UNT Libraries Government Documents Department
Collection:
Congressional Research Service Reports
Identifier:
Resource Type: Report
Format: Text